A high-level overview of Medicaid, including who it covers, how it is funded and administered, and why it is a key focus in current federal and state policy discussions.

As the U.S. considers pharmaceutical tariffs, this commentary offers a brief overview of the issue and its possible implications.

HHS has rescinded the Richardson Waiver, limiting public input on grants, contracts, and more. While aimed at efficiency, the change raises concerns about transparency and accountability in healthcare policymaking.

CBOH's Markus Saba, along with Kenan-Flagler Business School students, Tanya Aggarwal, Ashwin Ramanathan, and Stewart Spanbauer, have co-authored an article exploring Medicare Part D drug prices under the IRA.

CBOH's Markus Saba, along with UNC School of Medicine and Kenan-Flagler Business School MD/MBA dual degree student Austin Allen, have co-authored an article that offers a comprehensive overview of the current status and future direction of prior authorization.